NI
Nicox S.A.
NICXF · OTC
$0.30 +0.00% (+$0.00)
Market Cap 24.6M €
P/E Ratio -
Div. Yield -
ROE 438.40%
Bulios Fair Price
$0.27
10.0% downside
Trenutna cena
$0.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NICXF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
33 /100
Expensive P/B 7.20x
P/S 3.12x
EV/EBITDA N/A
Growth
5 /100
Declining Book val. growth 64.39%
Rev. growth 2.90%
FCF growth N/A
Profitability
22 /100
Weak Net margin 284.90%
Op. margin 125.38%
FCF margin 0.00%
Quality
4 /100
Poor ROE 438.40%
ROA 91.68%
Asset turnover 0.32x
Debt
50 /100
Moderate Current ratio 6.63x
Int. coverage -12.76x
Net debt/EBITDA -0.35x
Stability
45 /100
Moderate Rev. volatility 36.72%
EPS volatility 28.00%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NICXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gavin Spencer
Employees
10
Headquarters
Biot
Prihajajoči dogodki
03 MAR.
Earnings
Upcoming earnings report